1.

Use and misuse of antimicrobial agents in Flemish racing pigeons

1.

Aviair bornavirus en kliermaagdilatatiesyndroom bij psittaciformen

1.

Fluoroquinolone resistance in clinical avian pathogenic Escherichia coli (APEC) isolates from Flanders: Is the poultry industry at risk?

1.

Fluoroquinolone resistance in clinical avian pathogenic Escherichia coli isolates from Flanders (Belgium)

2.

Fluoroquinolone resistance in clinical avian pathogenic Escherichia coli isolates from Flanders (Belgium)

3.

Fluoroquinolone resistance in clinical avian pathogenic Escherichia coli isolates from Flanders (Belgium)

1.

Evaluation of fluoroquinolone resistance in clinical avian pathogenic Escherichia coli isolates from Flanders (Belgium)

2.

Evaluation of fluoroquinolone resistance in clinical avian pathogenic Escherichia coli isolates from Flanders (Belgium)

3.

Evaluation of fluoroquinolone resistance in clinical avian pathogenic Escherichia coli isolates from Flanders (Belgium)

1.

Comparative pharmacokinetics of celecoxib and mavacoxib in cockatiels (Nymphicus hollandicus)

1.

Development of an in vivo lipopolysaccharide inflammation model to study the pharmacodynamics of COX-2 inhibitors celecoxib, mavacoxib, and meloxicam in cockatiels (Nymphicus holla...

1.

The use of intratumoral chemotherapy in an integumentary squamous cell carcinoma in a cockatiel (Nymphicus hollandicus)

1.

Intratumoral chemotherapy in an integumentary squamous cell carcinoma in a cockatiel (Nymphicus hollandicus)

1.

Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)

2.

Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)

3.

Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)

4.

Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)

5.

Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)